A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer

Yuh Min Chen, Reury P. Perng, Kuang Y. Yang, Wei C. Lin, Hsiao W. Wu, Jacqueline M. Liu, Chun M. Tsai, Jacqueline Whang-Peng

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences